Clinical Research Directory

Inclusion Criteria: * Age 18-50 years, regardless of gender * Meet the diagnostic criteria for MASLD * Meet the diagnostic criteria for dampness-heat accumulation syndrome in Traditional Chinese Medicine * Liver controlled attenuation parameter (CAP) ≥238 dB/m * Body mass index (BMI) ≥23 kg/m² * Possess adequate cognitive and comprehension abilities to understand the study content, its potential risks, and benefits; * Voluntarily participate in this study and personally sign the informed consent form Exclusion Criteria: * Concurrent presence of other liver diseases that may lead to hepatic steatosis, specifically including drug-induced liver injury, alcoholic liver disease, autoimmune liver disease, viral hepatitis, and Wilson's disease * Concurrent severe dysfunction of major organs such as the heart, kidneys, or lungs, e.g., severe cardiac insufficiency (NYHA class III or higher), renal failure (estimated glomerular filtration rate \<30 mL/min/1.73 m²), or acute exacerbation of chronic obstructive pulmonary disease * Subjects currently receiving treatment for MASLD * Concurrent presence of other severe systemic diseases, such as malignant tumors or active systemic lupus erythematosus * Known hypersensitivity or intolerance to any component of the study drug * Pregnant women, lactating women, or women of childbearing age who refuse effective contraceptive measures during the trial * Participation in other clinical trials within the past 3 months * Other circumstances deemed by the investigator unsuitable for participation in this study, such as severe mental disorders affecting compliance with the study